2021
Myopericarditis with Significant Left Ventricular Dysfunction Following COVID-19 Vaccination: A Case Report
Bartlett VL, Thomas A, Hur DJ, Malm B. Myopericarditis with Significant Left Ventricular Dysfunction Following COVID-19 Vaccination: A Case Report. American Journal Of Case Reports 2021, 22: e934066-1-e934066-6. PMID: 34795198, PMCID: PMC8611472, DOI: 10.12659/ajcr.934066.Peer-Reviewed Case Reports and Technical NotesConceptsSignificant left ventricular dysfunctionLeft ventricular dysfunctionCOVID-19 vaccinationVentricular dysfunctionCOVID-19 vaccineCase reportNon-steroidal anti-inflammatory treatmentBNT162b2 COVID-19 vaccineAdverse effectsGreater cardiac dysfunctionAnti-inflammatory treatmentRare adverse effectMiddle-aged patientsSafety of vaccinesMiddle-aged menEmergency use authorizationMyopericarditis casesAdverse eventsVentricular functionCardiac dysfunctionSecond doseVaccinationMyopericarditisDysfunctionVaccine
2020
Access and Outcomes Among Hypertrophic Cardiomyopathy Patients in a Large Integrated Health System
Thomas A, Papoutsidakis N, Spatz E, Testani J, Soucier R, Chou J, Ahmad T, Darr U, Hu X, Li F, Chen ME, Bellumkonda L, Sumathipala A, Jacoby D. Access and Outcomes Among Hypertrophic Cardiomyopathy Patients in a Large Integrated Health System. Journal Of The American Heart Association 2020, 9: e014095. PMID: 31973610, PMCID: PMC7033886, DOI: 10.1161/jaha.119.014095.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedCardiomyopathy, HypertrophicCause of DeathConnecticutDelivery of Health Care, IntegratedFemaleHealthcare DisparitiesHeart Disease Risk FactorsHospitalizationHumansMaleMiddle AgedOutcome and Process Assessment, Health CareReferral and ConsultationRetrospective StudiesRisk AssessmentSocial ClassSocial Determinants of HealthTreatment OutcomeConceptsSpecialty careHCM patientsCare cohortHypertrophic cardiomyopathyYale New Haven Health SystemLarge integrated health systemHealth systemBackground Hypertrophic cardiomyopathyRetrospective cohort studySocioeconomic statusPatients' socioeconomic statusHigher socioeconomic status groupsHypertrophic cardiomyopathy patientsIntegrated health systemSpecialty care accessSocioeconomic status groupsMedical insurance providersCardiomyopathy clinicCause deathLSES patientsCause hospitalizationCause mortalityNoncardiac causesCohort studySecondary outcomes